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Detection of prion protein in the
cerebrospinal fluid of elk (Cervus
canadensis nelsoni) with chronic
wasting disease using protein
misfolding cyclic amplification
Tracy A. Nichols,1 Terry R. Spraker, Tom Gidlewski, Jenny G. Powers,
Glenn C. Telling, Kurt C. VerCauteren, Mark D. Zabel

Abstract. Cerebrospinal fluid (CSF) has been examined as a possible source for preclinical diagnosis of prion diseases
in hamsters and sheep. The present report describes the detection of chronic wasting disease (CWD) in the CSF of elk
and evaluates its usefulness as an antemortem test for CWD. The CSF from 6 captive and 31 free-ranging adult elk was
collected at necropsy and evaluated for the presence of the abnormal isoform of the prion protein that has been associated
with CWD (PrPCWD) via protein misfolding cyclic amplification. Additionally, the obex from each animal was examined by
immunohistochemistry (IHC). Four out of 6 captive animals were CWD-positive and euthanized due to signs of terminal
CWD. The remaining 2 were CWD negative. None of the 31 free-range animals showed overt signs of CWD, but 12 out of
31 tested positive for CWD by IHC. Protein misfolding cyclic amplification detected PrPCWD from 3 of the 4 captive animals
showing clinical signs of CWD and none of the nonclinical animals that were CWD positive by IHC. The data suggests that
CWD prions can be detected in the CSF of elk, but only relatively late in the course of the disease.
Key words: Cerebrospinal fluid; Cervus canadensis nelson; chronic wasting disease; protein misfolding cyclic
amplification; prion protein; Rocky Mountain elk.
Chronic wasting disease (CWD) is a fatal, infectious neurodegenerative disease that affects wild and captive cervids. It
is a transmissible spongiform encephalopathy, or prion disease. Development of an antemortem test for detecting the
misfolded prion protein associated with CWD (PrPCWD) in
nonclinical animals would be useful for wildlife and captive
population management strategies. To date, preclinical testing for PrPCWD utilizes immunohistochemistry (IHC) of the
palatine tonsils or rectal lymphoid tissues in cervids.18,21,24
However, IHC does not routinely detect very early cases of
CWD in these tissues.17,20 Various fluids, such as saliva,
blood, urine, and cerebrospinal fluid (CSF) have been evaluated in animals for their use in preclinical antemortem
detection of abnormal prions.4,6,10,22 Due to the minute concentrations of infectious proteins in saliva, blood, and urine,
detection of the misfolded infectious prion protein (PrPres)
has been limited or unsuccessful without the use of protein
misfolding cyclic amplification (PMCA), which increases
the concentration to a detectable level, and is orders of magnitude more sensitive for detecting PrPCWD than commonly
used methods such as Western blotting and IHC,7 enabling
detection of minute amounts of infectious prions in animal
tissues and environmental samples.9
In the current study, the usefulness of PMCA to detect
PrPCWD in CSF from wild and captive elk (Cervus canadensis

nelsoni) was evaluated as a potential tool for early detection
of PrPCWD. The PMCA in vitro technique amplifies minute
amounts of infectious prions by rapidly converting normal
cellular prion protein (PrPc) to PrPres.11,16 Cerebrospinal fluid
(5–15 ml) was collected at necropsy from 6 captive and 31
free-ranging, adult elk. Four of the 6 captive elk were euthanized due to positive CWD rectal biopsy results and terminal
clinical signs. Cerebrospinal fluid was collected during the
postmortem examination just prior to removal of the head.
The head was flexed dorsally, the ventral muscles severed,
the ventral aspect of the foramen magnum was exposed, and
CSF collected with an 18-gauge needle attached to a 12-cc
syringe. Great care was taken to ensure that the extraction site
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of the CSF was clean and without blood contamination.
Cerebrospinal fluid was frozen at –80ºC until samples were
analyzed using PMCA.
The CWD status of each elk was determined by examination of the obex at the level of the dorsal motor nucleus of the
vagus nerve by using previously described IHC techniques.18
The obex from all CWD-positive elk was scored as previously reported.19 Briefly, nuclear regions and axonal tracts
were evaluated and scored 0–10 for the severity of spongiform degeneration and accumulation of PrPCWD immuno
reactivity (IR). Tissue samples showing no detectable IR
received a score of zero, and samples showing heavy immunoreactivity in all nuclei and axons received a score of 10.
Brain homogenate from transgenic Tg5037 mice, which
express a 5-fold increase in elk PrPc, were used as a source of
PrPc substrate in the PMCA. reactions.2 A 10% (wt/vol) normal brain homogenate (NBH) was prepared as previously
described, utilizing a homogenizera at setting 6 for 5 min.9
Equivalent volumes of CSF and NBH (25 µl of each) were
added to individual 200-µl PCR tubes sealed with plastic
paraffin film with a paper backing and sonicatedb with 40-sec
pulses at 37°C, power setting 7, every 30 min for 24 hr. After
each 24-hr round, 25 µl of each sample was mixed with 25 µl
of fresh NBH and transferred to a fresh tube. A positive
amplification control of 1:100,000 CWD-positive brain
homogenate was also amplified with each sample group as
were NBH-negative controls. Duplicate samples were amplified in 3 independent replicate experiments for a total of
6 samples. Upon completion of 6 rounds, amplified samples
were digested with proteinase Kc and immunoblotted as previously described.9 The proteinase K–resistant core of PrPres
appears on Western blots as bands shifted below those seen
for full-length PrP. Only samples in which signal was
detected in 2 of the 3 replicate experiments were considered
positive.
The misfolded prion protein associated with CWD was
detected in 3 out of 4 captive, IHC-positive clinical elk (Fig. 1,
Table 1). However, the nonclinical, wild CWD IHC-positive
elk did not yield detectable CWD in the CSF (Table 1).
These animals were in generally good health, as indicated by
body and coat condition.
Although it is unknown how long the 3 PMCA-positive
elk had been infected, their obex scores ranged from 9 to 10
(Table 1), whereas the obex scores of 12 IHC-positive but
PMCA-negative nonclinical elk ranged from 2 to 9. Negative
captive elk had no detectable PrPCWD and therefore had
scores of 0. Previous studies involving sheep and hamsters
demonstrated that PrPres could be detected in the CSF.3,10
However, the present findings are not readily compared to
those previous results, which were derived exclusively from
terminal, clinical animals.3,10 Transport of prions to the brain
from distal regions such as the gut has been shown to occur
via movement along peripheral nerves and via the blood.14
Studies conducted in naturally and orally exposed sheep to
scrapie suggest that prions migrate from the gut-associated
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Figure 1. Western blots of captive elk cerebrospinal fluid
after 6 rounds of protein misfolding cyclic amplification. NBH =
normal brain homogenate negative controls. Positive control
1:100,000 dilution of chronic wasting disease–positive brain
homogenate. Chronic wasting disease was detected in captive elk
1–3. Representative of 3 replicates.
Table 1. Source, and protein misfolding cyclic amplification
(PMCA) and immunohistochemistry (IHC) results for 6 captive
and 31 free-ranging adult elk (Cervus canadensis nelsoni).
Elk ID

Source

PMCA results

IHC obex score

1
2
1
2
3
4
1
2
3
4
5
6
7
8
9
10
11
12
13
14–31

Captive
Captive
Captive
Captive
Captive
Captive
Free range
Free range
Free range
Free range
Free range
Free range
Free range
Free range
Free range
Free range
Free range
Free range
Free range
Free range

–
–
+
+
+
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–

0
0
9–10
9–10
9–10
9–10
0
9
4
8
7
4
7
7
2
2
6
5
6
0

lymph tissue to the central nervous system along nerve tracts
to the spinal cord and brain.1 A similar pattern of PrPCWD
deposition has been observed in deer.8,12,13,23 Chronic wasting
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disease has been detected in blood,6 and studies done in
sheep demonstrate that intravenous inoculation with scrapie
results in neuroinvasion and disease indistinguishable from
other routes of infection.15 It has been postulated in the literature that the circumventricular organs (CVO) in the brain
could be a site of entry for prions from the blood into the
brain.15 The CVO are specialized structures that line the third
and fourth ventricles of the brain and are considered to be
absent of the “blood-brain barrier.”5 As has been seen with
scrapie in sheep,15 PrPCWD can be detected in the CVO, with
the exception of the choroid plexus, in nonclinical deer and
elk with obex scores greater than 9 (with the obex scoring
system, clinical signs are usually not observed until obex
scores of 9 or 10 are achieved (unpublished data, 2005).
Early accumulation of scrapie in the CVO has prompted
some researchers to propose that because the CVO is devoid
of the blood-brain barrier, prions can cross unhampered from
the blood to the brain and then on to regional lymph nodes.15
The data suggests that in the earlier stages of disease, the
intact ependymal and CVO appear to sequester PrPCWD and
prevent infiltration of PrPCWD into the CSF. It is therefore
reasonable to propose that in the latter stages of disease, with
obex scores greater than 9, the PrPCWD begins to leak through
the epemdyma, allowing PrPCWD access to the CSF. Leakage
is not thought to be caused by autolysis at necropsy, as the
postmortem interval of the positive wild elk was 3–4 hr and
only 1 hr for the captive elk. In conclusion, the present data
suggests that PrPCWD infiltrates the CSF at relatively late
stages of CWD and that PMCA of CSF is not useful as a
diagnostic tool in nonclinical elk. Work needs to continue to
investigate other tissues such as saliva and lymph node biopsies as PMCA antemortem diagnostic specimens.
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